New report provides window onto EU drug market changes during COVID-19

This question is explored inEU Drug Markets: Impact of COVID-19, a new report out today from the EU drugs agency (EMCDDA) and Europol (1).

Metadata
Provider: 
ECEC
URL: 
https://www.emcdda.europa.eu/news/2020/3/new-report-provides-window-eu-drug-market-changes-during-covid-19_enhttps://www.emcdda.europa.eu/news/2020/3/new-report-provides-window-eu-drug-market-changes-during-covid-19_en
Retrieved on: 
Saturday, May 30, 2020
Information
Tags: 
Organizations, Government agencies, Government, Criminal investigation, Europol, Law enforcement in Europe, Agencies of the European Union, European Monitoring Centre for Drugs and Drug Addiction, Illegal drug trade, European Union
Summary
Key Points: 
  • This question is explored inEU Drug Markets: Impact of COVID-19, a new report out today from the EU drugs agency (EMCDDA) and Europol (1).
  • The two EU agencies have joined forces to improve understanding of drug market developments under COVID-19 and their impact on internal security and public health in the EU.
  • According to the report, disruption to the drug trafficking supply chain is seen mostly at the distribution level, due to social distancing measures within the EU.
  • This report provides valuable insights into the short-term impact of the pandemic on the EU drug market and will help us prepare for longer-term repercussions.
Copyright: 
2020 EC. All Rights Reserved.